Medicinal Cannabis Matters – Friday Roundup 22nd November.
Medicinal Cannabis Matters | Friday roundup 22nd November 2024.
Medicinal Cannabis Matters – Our weekly round-up of what has been happening in the world of medicinal cannabis this week.
This week, we look into how a new medicinal cannabis centre in the Isle of Man plan to tap into the Global Sector. We highlight a recent study on using oral cannabis extracts for chemotherapy, and how chronic pain is one of the most common reasons for medicinal cannabis treatment.
Medicinal Cannabis Centre plans to tap into the global sector.
Cultivating medicinal cannabis on the Isle of Man provides an opportunity to “tap into a global sector”. Mr Fray believes medicinal cannabis could “have a positive impact on the quality of life for people suffering from a wide range of conditions” The firm aims to build the facility within 12 months with goods being exported by 2026.
Positive results from a Study on Oral Cannabis Extract for Chemotherapy.
Tilray has announced positive results from a recent study using oral cannabis extract for the prevention of Chemotherapy-induced Nausea and Vomiting. The study also found that the cannabis extract significantly improved the rate of complete response – meaning no vomiting or using additional medications.
Report shows that chronic pain is one of the most common reasons for medicinal cannabis treatment.
Nearly one-third of medicinal cannabis patients have said chronic pain is the primary condition for their medicinal cannabis use. The study also found that more than 58% of patients use medical cannabis to manage two or more medical conditions.
If you’re interested in learning more about medicinal cannabis and how it can help you manage your condition, fill out the simple form linked below. Start your journey today with the only award-winning clinic in Jersey and Guernsey.
Check your eligibility.
https://www.medicann.co.uk/book-consultation/eligibility
Disclaimer:
This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.
